Table 4.

The effect of rHV3 eye drops on the activities of MDA, SOD, and GSH-Px in the lens on diabetic cataract in Sprague-Dawley rats ($\overline{x}\pm s$).

Group	n	MDA (nMol/mg prot)	SOD (U/mg prot)	GSH-Px (U/mg prot)
A	16	0.441 ± 0.07**	10.07 ± 1.77∗∗##	8.55 ± 1.83**
B	13	0.686 ± 0.16	4.75 ± 1.38	4.03 ± 1.31
C	13	0.513 ± 0.20	6.92 ± 1.52**	5.18 ± 1.77
D	14	0.482 ± 0.21*	7.84 ± 1.29**	7.84 ± 1.81**
E	15	0.456 ± 0.14**	8.21 ± 1.31**	9.73 ± 2.50∗∗##
F	12	0.478 ± 0.15*	7.08 ± 1.17**	6.82 ± 1.41**

 *P < 0.05, **P < 0.01 versus group B (model, treated with eye drops vehicle).

  ^# P < 0.05, ^## P < 0.01 versus group F (pirenoxine treated).